exp date isn't null, but text field is
Use only in accordance with protocols or on advice of Microbiology, Infectious Diseases or appropriate Consultant Specialist.
MHRA advice: Liposomal and lipid-complex formulations: name change to reduce medication errors (July 2020) (www.gov.uk).
MHRA advice: Parenteral amphotericin B: reminder of risk of potentially fatal adverse reaction if formulations confused (July 2018) (www.gov.uk).
Powder for dispersion for infusion 50mg (AmBisome Liposomal®) (s)
MHRA alert: Flucytosine (Ancotil): new contraindication in patients with DPD deficiency (October 2020) (www.gov.uk).
MHRA advice: Posaconazole (Noxafil): tablets and oral suspension are not directly interchangeable (September 2016) (www.gov.uk).
Oral suspension 200mg/5mL (hospital use only)
MHRA advice: Voriconazole: reminder of risk of liver toxicity, phototoxicity, and squamous cell carcinoma (December 2014) (www.gov.uk).
Risk minimisation materials
Oral suspension 200mg/5mL (Hospital use only)
Intravenous infusion 200mg (Hosptial use only)
